Search clinical trials for: KLH

Total 254 results

Ono Pharmaceutical Co. Ltd

Completed

Single Ascending Dose Study to Assess the Safety, Tolerability, PK and PD of ONO-4685 in Japanese and Caucasian Healthy Adult Male Subjects

Healthy Volunteers

Japan
University of Nebraska
Genitope Corporation

Completed

Idiotype Vaccine After Chemotherapy & Stem Cell Transplantation in Lymphoma With Failed Induction Chemotherapy

Lymphoma

United States
Kissei Pharmaceutical Co., Ltd.

Active, not recruiting

A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia and Pain

Uterine Fibroids (MeSH Heading: Leiomyoma)

Japan
GlaxoSmithKline

Completed

Characterisation of T-cell Response to Keyhole Limpet Hemocyanin (KLH) and Tuberculin Purified Protein Derivative (PPD)

Dermatitis

United Kingdom
Kissei Pharmaceutical Co., Ltd.

Completed

A Randomized Open Label Study of KLH-2109 in Patients With Endometriosis(1)

Endometriosis

Japan
Roswell Park Cancer Institute

No longer available

SurVaxM Expanded Access Protocol (EAP)

Glioblastoma
Biovest International

Unknown

Study of the BiovaxId Tumor Derived Idiotype Vaccine in Patients With Follicular Lymphoma (BiovaxID)

Non-Hodgkins Lymphoma
Kissei Pharmaceutical Co., Ltd.

Completed

A Phase II Randomized Open Label Study of KLH-2109 in Patients With Endometriosis

Endometriosis

Japan
Axon Neuroscience SE

Completed

18-months Safety Follow-up Study of AADvac1, an Active Tau Vaccine for Alzheimer's Disease (FUNDAMANT)

Alzheimer's Disease

Austria
Kissei Pharmaceutical Co., Ltd.

Completed

A Randomized, Placebo-controlled, Double-blind Study of KLH-2109 in Patients With Endometriosis (2)

Endometriosis

Japan
Memorial Sloan Kettering Cancer Center

Completed

Vaccination of Prostate Cancer Patients With MUC-2-KLH Conjugate Plus the Immunological Adjuvant QS21

Prostate Cancer

United States
National Institute of Allergy and Infectious Diseases...

Completed

Study of Immune Responses and Safety of Recombinant Human CD40 Ligand in Patients With X-Linked Hyper-IgM Syndrome

Immunoproliferative Disorder

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Vaccine Therapy Plus QS21 in Treating Women With Breast Cancer Who Have No Evidence of Disease

Breast Cancer

United States
San Carlo Public Hospital, Potenza, Italy

Completed

Luteal Phase Supplementation With Recombinant LH After GnRh Agonist Oocytes Triggering in Women at Risk of OHSS

Ovarian Hyperstimulation Syndrome

Italy
John Sampson
National Cancer Institute (NCI)

Completed

Chemotherapy, Radiation Therapy, and Vaccine Therapy With Basiliximab in Treating Patients With Glioblastoma Multiforme That Has Been Removed by Surgery (ZAP IT)

Malignant Neoplasms of Brain

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Breast Cancer

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Vaccine Therapy Plus QS21 in Treating Patients With Prostate Cancer

Prostate Cancer

United States
Dr. Nina Bhardwaj
Cancer Research Institute, New York City

Completed

Comparison of Dendritic Cells Versus Montanide as Adjuvants in a Melanoma Vaccine

Melanoma

United States
Masonic Cancer Center, University of Minnesota

Terminated

Vaccination With Tetanus and KLH to Assess Immune Responses.

Cancer

United States
National Cancer Institute (NCI)

Completed

Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines

Lymphoma | Follicular Lymphoma | B Cell Lymphoma

United States
National Institute of Allergy and Infectious Diseases...
Atopic Dermatitis and Vaccinia Network

Completed

Responses to Immunization With Keyhole Limpet Hemocyanin Administered by Scarification and the Intradermal Route

Atopic Dermatitis

United States
Favrille

Unknown

Idiotype Vaccine for Low-Grade Non-Hodgkin's Lymphoma

Lymphoma, Low-Grade

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer

Prostate Cancer

United States
National Institute of Allergy and Infectious Diseases...
Immune Tolerance Network (ITN)

Terminated

A Study to Determine the Immunogenicity and Oral Tolerance to Keyhole Limpet Hemocyanin (KLH)

Autoimmune Disorders

United States
Memorial Sloan Kettering Cancer Center

Completed

Determine Toxicity and Antibody Responses With a KLH Conjugated Bivalent Vaccine Containing GD2 Lactone, GD3 Lactone With Immunological Adjuvant QS-DG or OPT-821 in Patients With Disease Free AJCC Stage III or IV Cutaneous Melanoma

Melanoma

United States
Leo W. Jenkins Cancer Center
H. Lee Moffitt Cancer Center and Research Institute

Terminated

Direct Tumor Injection KLH-Pulsed Dendritic Cells in Unresectable Pancreatic Cancer

Metastatic Pancreatic Cancer

United States
Favrille

Unknown

Rituxan Plus FavId (Idiotype Vaccine) for Low-grade Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma

United States
European Organisation for Research and Treatment...

Unknown

Vaccine Therapy in Treating Patients With Primary Stage II Melanoma

Melanoma (Skin)

Italy, France, Spain, Switzerland, United Kingdom, Belgium, Australia, Norway, Poland, Finland, Netherlands, Germany, Israel, Denmark, Serbia, Estonia, Portugal, Russian Federation
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer

United States
M.D. Anderson Cancer Center

Terminated

Trial of ID-Specific Donor Vaccinated Lymphocyte Infusion for Patients With Myeloma Relapsing or Failing to Achieve a Complete Remission After an Allogenic Transplant

Myeloma

United States
Kingfisher Healthcare

Unknown

Chronic Venous ULcer TReatment Analyzing Bio-Electrical Stimulation Therapy

Chronic Venous Leg Ulcers

Belgium
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Vaccine Therapy Plus QS21 in Treating Patients With Prostate Cancer

Prostate Cancer

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Vaccine Therapy Plus Biological Therapy in Treating Patients With Prostate Cancer

Prostate Cancer

United States
Providence Health & Services

Completed

Phase 1 Study of Anti-OX40 in Patients With Advanced Cancer

Advanced Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Kyowa Hakko Kirin Pharma, Inc.

Recruiting

Phototherapy and Mogamulizumab in Early Stage MF (PLIGHT) (PLIGHT)

Mycosis Fungoides

United States
Hoffmann-La Roche

Completed

A Study to Assess Immune Response in Pediatric Kidney Transplant Recipients Treated With Daclizumab (Zenapax)

Kidney Transplantation

United States
Reproductive & Genetic Hospital of CITIC-Xiangya

Recruiting

Recombinant LH Supplementation Timing Strategies (From Day 1 or Day 6) to a Standard GnRH Agonist Long Protocol in Subsequent COS Cycle of Older Patients With Unexpected Poor or Suboptimal Ovarian Response

Infertility,Female

China
AngioLab, Inc.

Completed

A Study to Evaluate the Efficacy and Safety of ALH-L1005 in Patients With Chronic Periodontitis

Chronic Periodontitis

Korea, Republic of
University Magna Graecia

Unknown

Ovarian Reserve Modification After Lps Hysterectomy With Bilateral Salpingectomy

Pelvic Pain | Adenomyosis | Uterine Fibroids | Pelvic Prolapse

Italy
National Cancer Institute (NCI)

Completed

Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or Neuroblastoma

Sarcoma | Neuroectodermal Tumors, Primitive, Peripheral | Neuroblastoma | Rhabdomyosarcoma-Embryonal | Rhabdomyosarcoma- Alveolar

United States
Kolon Life Science

Enrolling by invitation

A Long-term, 3-Year, Follow-up Study for Patients Completing the KS-GIG-001-01 Study

Lumbosacral Radiculopathy

United States
CHA University

Completed

LESS-TLH Versus LESS-LAVH

Benign Uterine Disease

Korea, Republic of
Oslo University Hospital

Unknown

Long Term Outcomes Following Total Laparoscopic Hysterectomy and Laparoscopic Supracervical Hysterectomy

Dysmenorrhea | Total Laparoscopic Hysterectomy | Abnormal Uterine Bleeding | Laparoscopic Supracervical Hysterectomy | Fibromas

Norway
Hanyang University Seoul Hospital

Completed

Comparison of TLH and LAVH With Over Than 500g

Hysterectomy, Benign Uterine Diseases
Fred Hutchinson Cancer Research Center/University...
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Multiple Myeloma Who Have Undergone Stem Cell Transplantation

Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple Myeloma

United States
Southwest Oncology Group
National Cancer Institute (NCI)

Terminated

S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer

Gastric Cancer | Ovarian Cancer | Prostate Cancer | Brain Tumors

United States
Ain Shams Maternity Hospital

Recruiting

TLH With Prior Uterine Artery Clipping at Its Origin Versus Conventional TLH (TLH)

Total Laparoscopic Hysterectomy

Egypt
Izmir Katip Celebi University

Completed

Cardiorespiratory Responses to a Pilates Training Session and Treadmill Walking in Healthy Adults

Healthy

Turkey
Kissei Pharmaceutical Co., Ltd.

Completed

Phase 2 Study of KLS-0611 in Patients With Dry Eye Syndromes

Dry Eye Syndromes

Japan
KangLaiTe USA

Completed

Kanglaite Injection Phase I Study

Neoplasms | Solid Tumors Refractory To Standard Therapy

United States

Search clinical trials for: KLH

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations